Additional file 1 of Association between the MCP-1 -2518 A > G (rs1024611) polymorphism and susceptibility to type 2 diabetes mellitus and diabetic nephropathy: a meta-analysis

Additional file 1: Figure S1. Forest plot of T2DM risk with the dominant model (GG+GA vs. AA) (T2DM vs. healthy control) of the MCP-1 rs1024611 polymorphism. (A) for the overall populations and (B) genotyping method; (C) age- and sex- adjusted; (D) and comorbid chronic disease subgroups. Figure S2. Forest plot of DN risk with the dominant model (GG+GA vs. AA) (DN vs. healthy control) of the MCP-1 rs1024611 polymorphism. (A) for the overall populations and (B) genotyping method; (C) age- and sex- adjusted; (D) and comorbid chronic disease subgroups. Figure S3. Forest plot of DN risk with the dominant model (GG+GA vs. AA) (DN vs. T2DM) of the MCP-1 rs1024611 polymorphism. (A) for the overall populations and (B) genotyping method; (C) age- and sex- adjusted; (D) and comorbid chronic disease subgroups. Figure S4. Sensitivity analysis via deletion of each individual study (T2DM vs. healthy control). (A) for GG+GA vs. AA and (B) GG vs.GA + AA; (C) GG vs. AA; (D) GG vs. GA; (E) and G vs. A models. Figure S5. Sensitivity analysis via deletion of each individual study (DN vs. healthy control). (A) for GG+GA vs. AA and (B) GG vs.GA + AA; (C) GG vs. AA; (D) GG vs. GA; (E) and G vs. A models. Figure S6. Sensitivity analysis via deletion of each individual study (DN vs. T2DM). (A) for GG+GA vs. AA and (B) GG vs.GA + AA; (C) GG vs. AA; (D) GG vs. GA; (E) and G vs. A models. Table S1. The comprehensive search strategies for different databases. Table S2. Main characteristic of included observational studies evaluating the relationship between the MCP-1 rs1024611 polymorphism and DN/T2DM risk. Table S3. Meta-analysis of the association between the MCP-1 rs1024611polymorphism and T2DM risk (T2DM vs. healthy control). Table S4. Meta-analysis of the association between the MCP-1 rs1024611polymorphism and DN risk (DN vs. healthy control). Table S5. Meta-analysis of the association between the MCP-1 rs1024611polymorphism and DN risk (DN vs. T2DM).